Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | ABP 234 |
| Trade Name | |
| Synonyms | ABP234|ABP-234 |
| Drug Descriptions |
Limited information is currently available on ABP 234, a putative Keytruda (pembrolizumab) biosimilar (Sep 2024). |
| DrugClasses | Immune Checkpoint Inhibitor 150 PD-L1/PD-1 antibody 132 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| ABP 234 | ABP 234 | 0 | 0 |
| ABP 234 + Carboplatin + Pemetrexed Disodium | ABP 234 Carboplatin Pemetrexed Disodium | 0 | 1 |
| ABP 234 + Cisplatin + Pemetrexed Disodium | ABP 234 Cisplatin Pemetrexed Disodium | 0 | 1 |
| ABP 234 + Pemetrexed Disodium | ABP 234 Pemetrexed Disodium | 0 | 1 |